|
25.06.2024 20:41:36
|
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
|
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions Today, Profdoc AS, a 100% subsidiary of CompuGroup Medical SE & Co. KGaA, has entered into an agreement with the shareholders of Pridok AS to acquire 100% of the shares in Pridok AS. Pridok AS with its corporate seat in Tønsberg, Norway, offers a web-based digital patient journal system for the healthcare sector. In the financial year 2023, it generated revenues of approximately NOK 46.8 million (equals approximately EUR 4.1 million), which corresponds to a year-on-year growth rate of 32%. The consideration for the shares in Pridok AS amount to NOK 404.9 million (equals approximately EUR 35.7 million). Depending on Pridok AS’ development of the business in the financial years 2024 until 2028, additional consideration tranches may become payable up to an aggregate amount of NOK 185 million (approximately EUR 16.3 million). Closing of the transaction is expected on June 25, 2024 and is not subject to material conditions. End of Inside Information
25-Jun-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1932989 |
| End of Announcement | EQS News Service |
|
|
1932989 25-Jun-2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CompuGroup Medical SE & Co. KGaAmehr Nachrichten
|
18.11.24 |
TecDAX-Titel CompuGroup Medical SE-Aktie: So viel Verlust hätte ein Investment in CompuGroup Medical SE von vor 3 Jahren bedeutet (finanzen.at) | |
|
15.11.24 |
XETRA-Handel TecDAX startet in der Verlustzone (finanzen.at) | |
|
14.11.24 |
Aufschläge in Frankfurt: TecDAX zeigt sich zum Handelsende fester (finanzen.at) | |
|
14.11.24 |
Freundlicher Handel in Frankfurt: Börsianer lassen TecDAX am Nachmittag steigen (finanzen.at) | |
|
14.11.24 |
Gewinne in Frankfurt: TecDAX fester (finanzen.at) | |
|
14.11.24 |
TecDAX aktuell: TecDAX-Börsianer greifen zum Start zu (finanzen.at) | |
|
11.11.24 |
TecDAX-Wert CompuGroup Medical SE-Aktie: So viel Verlust hätte ein Investment in CompuGroup Medical SE von vor einem Jahr eingebracht (finanzen.at) | |
|
08.11.24 |
Verluste in Frankfurt: TecDAX präsentiert sich leichter (finanzen.at) |
Analysen zu CompuGroup Medical SE & Co. KGaAmehr Analysen
| 08.11.24 | CompuGroup Medical Buy | Baader Bank | |
| 08.11.24 | CompuGroup Medical Hold | Deutsche Bank AG | |
| 08.11.24 | CompuGroup Medical Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.24 | CompuGroup Medical Buy | Warburg Research | |
| 07.11.24 | CompuGroup Medical Buy | Baader Bank |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.